Back to the main directory
EarningsReview / Equity
- CONE: Adjusting Estimates for Equity Raise, Continued Strong Demand by Raymond James
- KVHI: Remain OP2 as Agile Continues to Ramp plus Photonic Chip Optionality by Raymond James
- SAIA: In-Line 3Q; Pricing Impressive, Early 2019 Outlook Remains Robust; TP to $75 by Raymond James
- New CEO swift to tackle loss-making business by BNP Paribas Exane
- Resilient Q3 in a troubled macro world by BNP Paribas Exane
- DSM: Solid Q3, Unchanged Nutrition Outlook, Low Exposure to Auto - TP Raised to €125 by Raymond James
- Norwegian Air Shuttle (Buy, TP: NOK250.00) - October traffic statistics preview by DnB Markets
- Outotec (Buy, TP: EUR4.90) - Visibility remains low by DnB Markets
- Trelleborg (Hold, TP: SEK180.00) - Leverage improving by DnB Markets
- AKKA Technologies : Excellent T3, mais le risk-reward ne nous semble pas suffisamment attractif by Oddo BHF
- Momentum to temper in 4Q by BNP Paribas Exane
- Novo Nordisk (Buy, TP: DKK380.00) - GLP-1 growth beats basal insulin by DnB Markets
- Final UK budget before Brexit: a new carbon tax in the event of a no-deal by Oddo BHF
- TGS Nopec (Hold, TP: NOK314.00) - Q3 on the soft side by DnB Markets
- Ocean Yield (Hold, TP: NOK73.00) - Good times, bad times by DnB Markets
- DNO (Buy, TP: NOK21.00) - Strong cash flow by DnB Markets
- ODDO BHF Small & MIDCAP MORNING NEWS - 11/01/2018 by Oddo BHF
- Clariant: ST Outlook Solid, MT/LT Outlook Driven By 'New Clariant' Execution by Raymond James
- Polarcus (Hold, TP: NOK2.20) - Awarded job, but fewer tenders by DnB Markets
- Waiting for more news by BNP Paribas Exane
- Turning a Corner? by BNP Paribas Exane
- Coloplast (Buy, TP: DKK745.00) - Weak 2018/19 guidance by DnB Markets
- CHRW: 3Q Slightly Ahead; Falling Truck Spot Rates a Double-Edged Sword? by Raymond James
- Novo Nordisk (Buy, TP: DKK380.00) - by DnB Markets
- FLSmidth (Buy, TP: DKK430.00) - Solid but uneventful Q3 expected by DnB Markets
- MASI: 3Q Revenue and EPS Beat As Expected Driven By Healthy Fundamentals by Raymond James
- CLH: 3Q EBITDA/FCF Beat; EBITDA Guide Raised on Strong Core Trends, FCF Held by Raymond James
- Hexagon Composites (Buy, TP: NOK27.00) - Light Duty relief, Low Pressure lid by DnB Markets
- Swedish Orphan Biovitrum (Buy, TP: SEK340.00) - It was not that bad by DnB Markets
- A frustrating quarter, but the upturn should be near by BNP Paribas Exane
- Jeronimo Martins: Still too Early to Jump in...Market Perform Maintained by Raymond James
- Telenet Group: Can Telenet Stop Its De-Rating? (Underperform, TP Cut to €35) by Raymond James
- DIN: Upgrade to Strong Buy on Momentum, Deep Discount Valuation by Raymond James
- Investment Daily 01/11/2018 by BNP Paribas Exane
- AKKA Technologies : Excellent Q3, but risk-reward trade not attractive enough, in our view by Oddo BHF
- DHT Holdings (Buy, TP: USD7.60) - 2020e asset values in focus by DnB Markets
- Le dernier budget britannique avant le Brexit : une nouvelle taxation carbone en cas de no-deal by Oddo BHF
- CHK: Upgrade to Outperform; WildHorse Acquisition Transforms the Narrative by Raymond James
- TGS Nopec (Hold, TP: NOK314.00) - Q3 on the soft side by DnB Markets
- Q3 18 Results on 14 November by BNP Paribas Exane
- ODDO BHF Small & MIDCAP MORNING NEWS - 01/11/2018 by Oddo BHF
- Carlsberg (Sell, TP: DKK670.00) - by DnB Markets
- Scandi Standard (Hold, TP: SEK60.00) - Still some waiting for Sweden to improve by DnB Markets
- TELENET: Back to Neutral after strong run by New Street Research
- VRSK: Solid Results; 21% Valuation Premium to Historical Average Keeps Us MP3 by Raymond James
- Back on track by BNP Paribas Exane
- Wallenius Wilhelmsen ASA (Buy, TP: NOK49.00) - All eyes set to be on rates by DnB Markets
- Q318 results and 15 questions for management by BNP Paribas Exane
- Danske Bank (Buy, TP: DKK185.00) - Business holding up well by DnB Markets
- Global Markets pressuring group RoTE by BNP Paribas Exane